These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28674259)

  • 1. Pinanamine Is a Promising Lead Compound against Influenza A Virus: Evidence from in Vitro and in Vivo Efficacy Compared to Amantadine.
    Li R; Yang C; Du Q; Zhao X; Jiang H; Hu W; Yang Z
    Biol Pharm Bull; 2017; 40(7):954-959. PubMed ID: 28674259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
    Rahman M; Hoque SA; Islam MA; Rahman SR
    Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus.
    Dong J; Chen S; Li R; Cui W; Jiang H; Ling Y; Yang Z; Hu W
    Eur J Med Chem; 2016 Jan; 108():605-615. PubMed ID: 26722757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
    Zhao X; Li R; Zhou Y; Xiao M; Ma C; Yang Z; Zeng S; Du Q; Yang C; Jiang H; Hu Y; Wang K; Mok CKP; Sun P; Dong J; Cui W; Wang J; Tu Y; Yang Z; Hu W
    J Med Chem; 2018 Jun; 61(12):5187-5198. PubMed ID: 29799746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD
    Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.
    Masihi KN; Schweiger B; Finsterbusch T; Hengel H
    J Chemother; 2007 Jun; 19(3):295-303. PubMed ID: 17594925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.
    Ma C; Zhang J; Wang J
    Mol Pharmacol; 2016 Sep; 90(3):188-98. PubMed ID: 27385729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
    Hu XP; Shao MM; Song X; Wu XL; Qi L; Zheng K; Fan L; Liao CH; Li CY; He J; Hu YJ; Wu HQ; Li SH; Zhang J; Zhang FX; He ZD
    J Ethnopharmacol; 2016 Feb; 179():128-36. PubMed ID: 26190352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways.
    Li Y; Lin Z; Guo M; Zhao M; Xia Y; Wang C; Xu T; Zhu B
    Int J Nanomedicine; 2018; 13():2005-2016. PubMed ID: 29662313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo.
    Zhang Y; Yao J; Qi X; Liu X; Lu X; Feng G
    Antivir Ther; 2017; 22(7):599-611. PubMed ID: 28272019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: first report from Mumbai.
    Gohil DJ; Kothari ST; Shinde PS; Chintakrindi AS; Meharunkar R; Warke RV; Kanyalkar MA; Chowdhary AS; Deshmukh RA
    Infect Genet Evol; 2015 Jan; 29():75-81. PubMed ID: 25461259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.
    Liu Q; Xiong HR; Lu L; Liu YY; Luo F; Hou W; Yang ZQ
    Acta Pharmacol Sin; 2013 Aug; 34(8):1075-83. PubMed ID: 23770981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of recombinant mouse β-defensin 3 against influenza A virus in vitro and in vivo.
    Jiang Y; Yang D; Li W; Wang B; Jiang Z; Li M
    Antivir Chem Chemother; 2012 Aug; 22(6):255-62. PubMed ID: 22345365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.